Join us for our Abstract Highlights - ADA Scientific Sessions 2011 - Pioglitazone Therapy.

Participants in the 2011 ADA Scientific Sessions discussed the follow-up of patients enrolled in the ACT NOW study and how it suggests that the vascular protection of pioglitazone therapy in patients with impaired glucose tolerance is not explained by concurrent improvements in metabolic risk factors.

Check back daily for our updated reports.

For more information on the abstracts presented at the 2011 ADA Scientific Sessions, please visit:Professional.Diabetes.org